PYX Resources: Achieving volume and diversification milestones. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGeiger Counter Regulatory News (GCL)

Share Price Information for Geiger Counter (GCL)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 53.00
Bid: 52.00
Ask: 54.00
Change: 1.50 (2.86%)
Spread: 2.00 (3.846%)
Open: 52.50
High: 54.00
Low: 54.00
Prev. Close: 52.50
GCL Live PriceLast checked at -
Geiger Counter is an Investment Trust

To deliver attractive returns to shareholders principally in the form of capital growth, through investment in companies involved in the exploration, development and production of uranium to supply the nuclear power industry.

Find out More

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Results of AGM

13 Mar 2023 14:00

RNS Number : 7854S
Geiger Counter Ltd
13 March 2023
 

13 March 2023

GEIGER COUNTER LIMITED (THE "COMPANY")

 

Results of the Annual General Meeting

Geiger Counter Limited held it's Annual General Meeting on the 9 March 2023 at Ordnance House, 31 Pier Road, St Helier, Jersey.

The Chairman of the AGM is pleased to report that the following ordinary resolutions, each as listed in the notice of annual general meeting distributed in December 2022, were passed by the members:

1. To receive and adopt the Report of the Directors and the financial statements of the Company for the year ended 30 September 2022, together with the auditor's report thereon.

§ 13 votes in favour of the resolution representing 12,915,372 shares;

§ No votes against; and

§ 2 votes withheld representing 280,880 shares;

 

2. That KPMG Channel Islands Limited, Chartered Accountants, be re-appointed as Auditor and that the Directors be authorised to determine their remuneration.

§ 13 votes in favour of the resolution representing 12,897,508 shares;

§ 1 vote against representing 6,861 shares; and

§ 2 votes withheld representing 291,883 shares.

 

3. To approve the Directors' Remuneration Report for the year ended 30 September 2022.

§ 13 votes in favour of the resolution representing 12,792,151 shares;

§ 4 votes against representing 47,456 shares; and

§ 3 votes withheld representing 356,645 shares.

 

4. That, pursuant to article 45.1 of the Articles of Association of the Company ("the Articles"), the Directors shall extend the life of the Company from the fifteenth anniversary of the First Closing Date until the next annual general meeting of the Company, when a further extension will be sought.

§ 13 votes in favour of the resolution representing 12,912,097 shares;

§ No votes against; and

§ 2 votes withheld representing 284,155 shares;

 

 

5. That ordinary shares (the "new shares") may be issued by the Company in one or more tranches over a period from the date of the AGM to the next AGM of the Company, at a premium over the net asset value per share and that such issue of new shares is approved in accordance with article 6.1 of the Company's Articles.

§ 13 votes in favour of the resolution representing 12,646,230 shares;

§ 4 votes against representing 212,187 shares; and

§ 3 votes withheld representing 337,835 shares.

 

6. To re-elect Gary Clark, a Director retiring by rotation, as a Director.

§ 13 votes in favour of the resolution representing 12,876,195 shares;

§ 1 vote withheld representing 6,861 shares; and

§ 3 votes withheld representing 313,196 shares.

 

7. To re-elect James Leahy, a Director retiring by rotation, as a Director.

§ 13 votes in favour of the resolution representing 12,876,195 shares;

§ 1 vote withheld representing 6,861 shares; and

§ 3 votes withheld representing 313,196 shares.

 

8. To re-elect Professor Ian Reeves CBE as a Director.

§ 13 votes in favour of the resolution representing 12,876,195 shares;

§ 1 vote withheld representing 6,861 shares; and

§ 3 votes withheld representing 313,196 shares.

9. The Chairman is pleased to report that the following special resolution, as listed in the notice of Annual General Meeting distributed in December 2022, was passed by the members:

That the Company be and is hereby generally and unconditionally authorised, pursuant to and in accordance with article 57 of the Companies (Jersey) Law, 1991 (as amended) (the "Law") to make market purchases of its own ordinary shares in the capital of the Company (the "ordinary shares") on such terms and in such manner as the Directors of the Company shall from time to time determine, provided that:

a) the maximum aggregate number of ordinary shares hereby authorised to be purchased shall be such number as represents 14.99 per cent of the aggregate number of ordinary shares in issue as at 9 March 2023.

b) the minimum price which may be paid for an ordinary share shall be 1p;

c) the maximum price exclusive of any expenses which may be paid for an ordinary share is an amount equal to the higher of 5 per cent above the average of the middle market quotations for an ordinary share as derived from the London Stock Exchange for the five business days immediately preceding the date on which such ordinary share is contracted to be purchased;

d) the authority hereby conferred shall expire on 18 months from the date of this Special Resolution, unless previously revoked, varied or renewed by the Company in general meeting;

e) the Company may at any time prior to the expiry of such authority make a contract or contracts to purchase ordinary shares under such authority which will or might be completed or executed wholly or partly after the expiration of such authority and may make a purchase of ordinary shares in pursuance of any such contract or contracts;

f) the Directors of the Company provide a statement of solvency in accordance with articles 55-57 of the Law; and

g) such shares are acquired to be held in treasury.

§ 12 votes in favour of the resolution representing 12,879,804 shares;

§ 1 vote withheld representing 32,293 shares; and

§ 2 votes withheld representing 284,155 shares.

 

Enquiries

 

CQS (UK) LLP

Craig Cleland

T: +44 (0) 20 7201 5368

finnCap Limited

William Marle/Milesh Hindocha (Corporate Finance)

T: +44 (0) 20 7220 0500

Mark Whitfeld / Pauline Tribe (Sales)

T: +44 (0) 20 7220 0500

R&H Fund Services (Jersey) Limited

Jane De Barros-Sousa

T :+44 (0) 1534 825 259

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
RAGNKNBNNBKDFND
Date   Source Headline
24th Jul 20233:30 pmRNSNet Asset Value(s)
21st Jul 20232:15 pmRNSNet Asset Value(s)
20th Jul 20231:45 pmRNSNet Asset Value(s)
19th Jul 20232:45 pmRNSNet Asset Value(s)
18th Jul 20232:20 pmRNSNet Asset Value(s)
17th Jul 202312:40 pmRNSNet Asset Value(s)
14th Jul 202312:50 pmRNSNet Asset Value(s)
13th Jul 20232:00 pmRNSNet Asset Value(s)
12th Jul 20232:45 pmRNSNet Asset Value(s)
11th Jul 20232:30 pmRNSNet Asset Value(s)
10th Jul 20231:00 pmRNSNet Asset Value(s)
7th Jul 20234:00 pmRNSNet Asset Value(s)
6th Jul 20232:15 pmRNSNet Asset Value(s)
5th Jul 20232:00 pmRNSNet Asset Value(s)
4th Jul 20232:15 pmRNSNet Asset Value(s)
3rd Jul 20232:45 pmRNSNet Asset Value(s)
30th Jun 20234:30 pmRNSNet Asset Value(s)
30th Jun 202310:30 amRNSInterim Report and Financial Statements
29th Jun 20231:30 pmRNSNet Asset Value(s)
28th Jun 20232:15 pmRNSNet Asset Value(s)
27th Jun 20234:00 pmRNSNet Asset Value(s)
26th Jun 20234:55 pmRNSNet Asset Value(s)
23rd Jun 20233:00 pmRNSNet Asset Value(s)
22nd Jun 20233:15 pmRNSNet Asset Value(s)
21st Jun 20232:15 pmRNSNet Asset Value(s)
20th Jun 20231:40 pmRNSNet Asset Value(s)
19th Jun 20233:05 pmRNSNet Asset Value(s)
16th Jun 20232:30 pmRNSNet Asset Value(s)
15th Jun 202311:40 amRNSNet Asset Value(s)
14th Jun 202311:45 amRNSNet Asset Value(s)
13th Jun 20232:25 pmRNSNet Asset Value(s)
12th Jun 20232:05 pmRNSNet Asset Value(s)
9th Jun 202311:40 amRNSNet Asset Value(s)
8th Jun 202312:45 pmRNSNet Asset Value(s)
7th Jun 20233:15 pmRNSNet Asset Value(s)
6th Jun 20232:15 pmRNSNet Asset Value(s)
5th Jun 20232:25 pmRNSNet Asset Value(s)
2nd Jun 20231:10 pmRNSNet Asset Value(s)
1st Jun 20233:15 pmRNSNet Asset Value(s)
31st May 202312:10 pmRNSNet Asset Value(s)
30th May 20233:15 pmRNSNet Asset Value(s)
26th May 20232:35 pmRNSNet Asset Value(s)
25th May 202312:25 pmRNSNet Asset Value(s)
24th May 20231:05 pmRNSNet Asset Value(s)
23rd May 20232:20 pmRNSNet Asset Value(s)
22nd May 20232:25 pmRNSNet Asset Value(s)
19th May 202311:55 amRNSNet Asset Value(s)
18th May 202312:20 pmRNSNet Asset Value(s)
17th May 202312:05 pmRNSNet Asset Value(s)
16th May 20232:15 pmRNSNet Asset Value(s)

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.